Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorraine A Fitzpatrick

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2008
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosisE Michael Lewiecki, Tony M Keaveny, David L Kopperdahl, et al.
Mayo Clinic Proceedings|June 14, 2005
Calcification of the coronary arteries in the absence of atherosclerotic plaqueJian-Hua Qiao, Terence M Doherty, Michael C Fishbein, et al.
Calcified Tissue International|May 9, 2018
A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical ImplicationsLuciano Colangelo, Cristiana Cipriani, Jessica Pepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroadsTerence M Doherty, Kamlesh Asotra, Lorraine A Fitzpatrick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
The state of pediatric bone: summary of the ASBMR pediatric bone initiativeGordon L Klein, Lorraine A Fitzpatrick, Craig B Langman, et al.
Mayo Clinic Proceedings|February 6, 2017
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend TrialFelicia Cosman, Paul D Miller, Gregory C Williams, et al.
Cancer|November 25, 2003
Parathyroid carcinoma: is there a role for adjuvant radiation therapy?Nathan D Munson, Robert L Foote, Robert C Northcutt, et al.
Journal of Drug Assessment|August 19, 2016
Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristicsLorraine A Fitzpatrick, John P Bilezikian, Margaret Wooddell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 8, 2016
Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study EndpointColin G Miller, Cesar C Bogado, Antonio J Nino, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2008
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosisE Michael Lewiecki, Tony M Keaveny, David L Kopperdahl, et al.
Mayo Clinic Proceedings|June 14, 2005
Calcification of the coronary arteries in the absence of atherosclerotic plaqueJian-Hua Qiao, Terence M Doherty, Michael C Fishbein, et al.
Calcified Tissue International|May 9, 2018
A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical ImplicationsLuciano Colangelo, Cristiana Cipriani, Jessica Pepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroadsTerence M Doherty, Kamlesh Asotra, Lorraine A Fitzpatrick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
The state of pediatric bone: summary of the ASBMR pediatric bone initiativeGordon L Klein, Lorraine A Fitzpatrick, Craig B Langman, et al.
Mayo Clinic Proceedings|February 6, 2017
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend TrialFelicia Cosman, Paul D Miller, Gregory C Williams, et al.
Cancer|November 25, 2003
Parathyroid carcinoma: is there a role for adjuvant radiation therapy?Nathan D Munson, Robert L Foote, Robert C Northcutt, et al.
Journal of Drug Assessment|August 19, 2016
Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristicsLorraine A Fitzpatrick, John P Bilezikian, Margaret Wooddell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 8, 2016
Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study EndpointColin G Miller, Cesar C Bogado, Antonio J Nino, et al.
Pageof 7